These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11120049)

  • 41. FTY720 inhibits the mRNA expression of intragraft cytotoxic molecules, leading to cardiac allograft survival.
    Nakajima H; Sun E; Mizuta N; Fujiwara I; Oka T
    Transplant Proc; 1998 Aug; 30(5):2217-20. PubMed ID: 9723446
    [No Abstract]   [Full Text] [Related]  

  • 42. Long-term graft acceptance in allografted rats and dogs by treatment with a novel immunosuppressant, FTY720.
    Suzuki S; Enosawa S; Kakefuda T; Amemiya H; Hoshino Y; Chiba K
    Transplant Proc; 1996 Jun; 28(3):1375-6. PubMed ID: 8658701
    [No Abstract]   [Full Text] [Related]  

  • 43. CTLA4-Ig treatment prolongs rat orthotopic liver graft survival.
    Tu Y; Rehman A; Flye MW
    Transplant Proc; 1997; 29(1-2):1036-7. PubMed ID: 9123186
    [No Abstract]   [Full Text] [Related]  

  • 44. The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD.
    Nikolova Z; Hof A; Baumlin Y; Hof RP
    Transpl Immunol; 2000 Jun; 8(2):115-24. PubMed ID: 11005317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Agonistic and antagonistic interactions between CTLA4Ig and donor alloantigens in sensitized rat recipients of cardiac allografts.
    Onodera K; Chandraker A; Korom S; Stadlbauer TH; Kato K; Kasai S; Sayegh MH; Kupiec-Weglinski JW
    Transplant Proc; 1998 Feb; 30(1):16-8. PubMed ID: 9474943
    [No Abstract]   [Full Text] [Related]  

  • 46. CTLA4Ig inhibits alloantibody responses to transfusions and transplants.
    Ibrahim S; Jakobs F; Linsley PS; Sanfilippo F; Baldwin WM
    Transplant Proc; 1997; 29(1-2):1025. PubMed ID: 9123179
    [No Abstract]   [Full Text] [Related]  

  • 47. Pretreatment with FTY720 alone induced long-term survival of mouse heart allograft.
    Zhang L; Zhu T; Sun EW; Shen SQ; Min ZL; Chen ZK
    Transplant Proc; 2003 Feb; 35(1):567-8. PubMed ID: 12591534
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunosuppressive effect of FTY 720 on rat pancreas allograft.
    Suzuki K; Kazui T; Kawabe A; Li XK; Funeshima N; Amemiya H; Suzuki S
    Transplant Proc; 1998 Nov; 30(7):3417-8. PubMed ID: 9838506
    [No Abstract]   [Full Text] [Related]  

  • 49. Suppression of graft coronary arteriosclerosis by gene gun-mediated CTLA4-Ig gene transfer.
    Matsuno Y; Iwata H; Yoshikawa S; Umeda Y; Iida Y; Takagi H; Mori Y; Miyazaki J; Kosugi A; Hirose H
    Transplant Proc; 2002 Nov; 34(7):2619-21. PubMed ID: 12431547
    [No Abstract]   [Full Text] [Related]  

  • 50. A short-course therapy with FTY720 prolongs allograft survival after canine kidney transplantation.
    Omura T; Suzuki T; Shimamura T; Jin MB; Yokota R; Fukai M; Iida J; Taniguchi M; Magata S; Horiuchi H; Yamashita K; Nomura M; Kishida A; Matsushita M; Furukawa H; Todo S
    Transplant Proc; 1999 Nov; 31(7):2783-4. PubMed ID: 10578289
    [No Abstract]   [Full Text] [Related]  

  • 51. FTY720 prevents chronic rejection of rat heterotopic cardiac allografts.
    Chueh SC; Chen JR; Chen J; Lai MK
    Transplant Proc; 2001; 33(1-2):542-3. PubMed ID: 11266948
    [No Abstract]   [Full Text] [Related]  

  • 52. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2.
    Onodera K; Chandraker A; Volk HD; Ritter T; Lehmann M; Kato H; Sayegh MH; Kupiec-Weglinski JW
    Transplantation; 1999 Jul; 68(2):288-93. PubMed ID: 10440403
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD4-targeted therapy and CD28-B7 costimulatory blockage may independently induce tolerance in sensitized allograft recipients.
    Kato H; Onodera K; Chandraker A; Volk HD; Sayegh MH; Kupiec-Weglinski JW
    Transplant Proc; 1998 Jun; 30(4):1063-4. PubMed ID: 9636430
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of peritransplant FTY720 alone or in combination with post-transplant tacrolimus in a rat model of cardiac allotransplantation.
    Xu M; Pirenne J; Antoniou EA; Afford SC; D'Silva M; McMaster P
    Transpl Int; 1998; 11(4):288-94. PubMed ID: 9704394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CTLA4Ig alone or in combination with low-dose cyclosporine fails to reverse acute rejection of renal allograft in the rat.
    Perico N; Amuchastegui S; Bontempelli M; Remuzzi G
    Transplantation; 1996 May; 61(9):1320-2. PubMed ID: 8629290
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunosuppressive effect of a new drug, FTY720, on lymphocyte responses in vitro and cardiac allograft survival in rats.
    Suzuki S; Enosawa S; Kakefuda T; Li XK; Mitsusada M; Takahara S; Amemiya H
    Transpl Immunol; 1996 Sep; 4(3):252-5. PubMed ID: 8893458
    [No Abstract]   [Full Text] [Related]  

  • 57. Feasibility of immunosuppression in composite tissue allografts by systemic administration of CTLA4Ig.
    Iwasaki N; Gohda T; Yoshioka C; Murakami M; Inobe M; Minami A; Uede T
    Transplantation; 2002 Feb; 73(3):334-40. PubMed ID: 11884927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FTY720 blocks allograft rejection by homing of lymphocytes in vivo.
    Yuzawa K; Stephkowski SM; Wang M; Kahan BD
    Transplant Proc; 2000 Mar; 32(2):269. PubMed ID: 10715413
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate.
    Chiba K; Hoshino Y; Ohtsuki M; Kataoka H; Maeda Y; Matsuyuki H; Sugahara K; Kiuchi M; Hirose R; Adachi K
    Transplant Proc; 2005; 37(1):102-6. PubMed ID: 15808561
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Distinct tolerance pathways in sensitized rat recipients after blockade of activation signal 1 and signal 2.
    Onodera K; Chandraker A; Kato H; Volk HD; Sayegh MH; Kupiec-Weglinski JW
    Transplant Proc; 1999; 31(1-2):876-7. PubMed ID: 10083384
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.